Bhaskar Somani is a Professor of Urology and a Consultant Endourologist at University Hospital Southampton – MRCS, DM, FEBU, FFSTEd, FRCS (Urol)

Professor Bhaskar Somani has been involved in clinically innovative patient-centred treatments.  His research includes minimally invasive surgical techniques in management of kidney stone disease, enlarged prostate (BPH), renal cancer and urinary tract infections. He is the Clinical Director of ‘South Coast Lithotripter Services’.

Over the last 8 years his clinical and research work has been covered by BBC, ITV, Daily Mail, The Telegraph and other newspapers and media articles on a number of occasions. He has raised awareness in highlighting risk factors for development of kidney stones such as dehydration, diet and obesity.

He is an active member of BAUS Endourology sub-section and is the Wessex Clinical Research Network and Simulation Lead for Urology. He is the President of PETRA (Progress in Endourology, Technology and Research Association) Urogroup, an active member of European School of Urology (ESU) Training and Research group and EAU section of uro-technology (ESUT) endourology group. He is also the chosen representative for UK in the Endourology society.

His current research interests include vaccination for urinary tract infections, new minimally invasive prostate treatments, laser surgery for eroded vaginal mesh, complex renal stone surgery and post-surgery quality of life measurements. He is the advisor to National Institute for Health and Clinical Excellence (NICE) Interventional committee and ‘invited expert’ to NICE Urological infection guidelines.

He coordinates the largest hands-on-training simulation course for urology in the world (EAU-EUREP). He has published over 250 scientific papers and has been invited as a speaker, to perform live surgery and for moderations in more than 25 countries worldwide. He has also amassed a grant income of £1.6 million. With dedication, commitment and passion for research and teaching, he collaborates nationally and internationally sharing his research and teaching successfully across the world. He has published excellent clinical outcomes and his outcome and research translate into patient benefit. 

Bhaskar Somani is a Professor of Urology and a Consultant Endourologist at University Hospital Southampton – MRCS, DM, FEBU, FFSTEd, FRCS (Urol)

Professor Bhaskar Somani has been involved in clinically innovative patient-centred treatments.  His research includes minimally invasive surgical techniques in management of kidney stone disease, enlarged prostate (BPH), renal cancer and urinary tract infections. He is the Clinical Director of ‘South Coast Lithotripter Services’.

Over the last 8 years his clinical and research work has been covered by BBC, ITV, Daily Mail, The Telegraph and other newspapers and media articles on a number of occasions. He has raised awareness in highlighting risk factors for development of kidney stones such as dehydration, diet and obesity.

He is an active member of BAUS Endourology sub-section and is the Wessex Clinical Research Network and Simulation Lead for Urology. He is the President of PETRA (Progress in Endourology, Technology and Research Association) Urogroup, an active member of European School of Urology (ESU) Training and Research group and EAU section of uro-technology (ESUT) endourology group. He is also the chosen representative for UK in the Endourology society.

His current research interests include vaccination for urinary tract infections, new minimally invasive prostate treatments, laser surgery for eroded vaginal mesh, complex renal stone surgery and post-surgery quality of life measurements. He is the advisor to National Institute for Health and Clinical Excellence (NICE) Interventional committee and ‘invited expert’ to NICE Urological infection guidelines.

He coordinates the largest hands-on-training simulation course for urology in the world (EAU-EUREP). He has published over 250 scientific papers and has been invited as a speaker, to perform live surgery and for moderations in more than 25 countries worldwide. He has also amassed a grant income of £1.6 million. With dedication, commitment and passion for research and teaching, he collaborates nationally and internationally sharing his research and teaching successfully across the world. He has published excellent clinical outcomes and his outcome and research translate into patient benefit.